- Home
- PUMP vs BBOT Comparison
PUMP vs BBOT Comparison
Compare PUMP & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PUMP | BBOT |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PUMP | BBOT |
|---|---|---|
| Price | $13.93 | $9.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $14.14 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 2.2M | 309.1K |
| Earning Date | 04-29-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.76 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,269,158,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.98 | N/A |
| P/E Ratio | $1,396.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.51 | $8.08 |
| 52 Week High | $15.49 | $14.87 |
Technical Indicators
Market Signals| Indicator | PUMP | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 51.23 |
| Support Level | $13.67 | $8.80 |
| Resistance Level | $15.34 | $12.36 |
| Average True Range (ATR) | 0.66 | 0.53 |
| MACD | -0.09 | 0.13 |
| Stochastic Oscillator | 46.39 | 77.80 |
Price Performance
Historical ComparisonAbout PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.